lead has been researched along with donepezil in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, S; Gong, Q; Li, W; Li, X; Liu, J; Liu, Y; Onuwaje, I; Phillips, J; Uras, G; Xu, J; Xu, S; Yao, H; Zhang, H; Zhu, Z | 1 |
1 other study(ies) available for lead and donepezil
| Article | Year |
|---|---|
Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Donepezil; Lead; Mice; Neuroprotection; Neuroprotective Agents; Structure-Activity Relationship | 2022 |